LIVE MARKET TRACKER :   BSE SENSEX   27566.39      |    NSE NIFTY 8234.00    
GLOBAL MARKETS :  NASDAQ 4566.138   +0.37%    |    FSI London 6463.55   +0.15%    |    NIKKEI Japan 15901.88   +1.56%
  USD GBP EUR CAD AUD INR
USD - 0.6259 0.7944 1.1202 1.1353 61.36
GBP 1.598 - 1.2695 1.79 1.8143 98.0539
EUR 1.2589 0.7879 - 1.4102 1.4293 77.2486
CAD 0.8928 0.5588 0.7092 - 1.0136 54.7813
AUD 0.881 0.5514 0.6999 0.9868 - 54.0563
INR 0.0163 0.0102 0.0129 0.0183 0.0185 -
Indian-Commodity  :  Equity & Shares  :  Dr Reddy's Lab gains on introducing PamorelinO LA - cancer drug

Dr Reddy's Lab gains on introducing PamorelinO LA - cancer drug (10-Dec-2012)

Dr Reddy's Lab is currently trading at Rs. 1845.00, up by 6.65 points or 0.36% from its previous closing of Rs. 1838.35 on the BSE.

The scrip opened at Rs. 1844.80 and has touched a high and low of Rs. 1846.95 and Rs. 1833.70 respectively. So far 1923 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 5 has touched a 52 week high of Rs. 1850.00 on 06-Dec-2012 and a 52 week low of Rs. 1528.00 on 19-Jun-2012.

Last one week high and low of the scrip stood at Rs. 1850.00 and Rs. 1804.00 respectively. The current market cap of the company is Rs. 31,321 crore.

The promoters holding in the company stood at 25.56% while Institutions and Non-Institutions held 39.75% and 17.76% respectively.

Dr Reddy's Laboratories, has introduced PamorelinO LA in India under an exclusive marketing and sales agreement with Debiopharm Group, Switzerland. The company will import this drug in bulk from Debio Recherche Pharmaceutique and made available primarily to urologists and oncologists across India. PamorelinO LA is used for the treatment of locally advanced or metastatic, hormone-dependent prostate cancer.

Dr Reddy's is an integrated global pharmaceutical company, committed to providing affordable and innovative medicines for healthier lives. Through its three businesses - Pharmaceutical Services and Active Ingredients, Global Generics and Proprietary Products - the company offers a portfolio of products and services including APIs, custom pharmaceutical services, generics, bio-similars, differentiated formulations and NCEs 


Top News Today
Adani Power, Lanco Infratech, BPCL and Thermax to see some action today
(31-Oct-2014)

Adani Power, Lanco Infratech, BPCL and Thermax to see some action todayThe Competition Commission of India (CCI) has cleared Adani Power's proposed deal with Lanco Infratech to buy latter's 1,200-MW imported coal-fired power plant at Udupi in Karnataka for more than Rs 6,000......click on news to read complete article.

IL&FS Engineering, Kridhan Infra and GMDC to see some action today
(30-Oct-2014)

IL&FS Engineering, Kridhan Infra and GMDC to see some action todayIL&FS Engineering and Construction Company has won contracts from WBSEDCL (West Bengal State Electricity Distribution Company) for construction of Rural Electrification Infrastructure, Erection......click on news to read complete article.

Moody's retain negative outlook on Indian banks on high corporate leverage
(30-Oct-2014)

MoodyIn yet another worrying development for banking sector, international rating agency, Moody's while retaining its negative outlook for the Indian banking sector, has underscored that high leverage in the......click on news to read complete article.

International Stock News
US markets gain on encouraging GDP data
(31-Oct-2014)

US markets gain on encouraging GDP dataThe US markets closed higher on Thursday, as report showed faster-than-estimated growth in gross domestic product, fueling speculation that economy is strong enough to withstand higher interest rates.......click on news to read complete article.

US markets closed lower after Fed ends QE
(30-Oct-2014)

US markets closed lower after Fed ends QEThe US markets closed lower on Wednesday, with Dow Jones Industrial Average snapping a four-day winning streak, after the Federal Reserve made official its plans to end the last round of its recession-era......click on news to read complete article.

US markets climb higher ahead of FOMC meet
(29-Oct-2014)

US markets climb higher ahead of FOMC meetThe US markets rallied on Wednesday, ahead of the Federal Reserve's two-day policy meeting. Federal Reserve officials are widely expected to announce the end to the 2008-era bond-buying stimulus program,......click on news to read complete article.

 

     
  
Recent Equity & Shares News
 
EquityInvestmentCompany ReportsIPO
Disclaimer
By clicking on this page you accept all the terms and conditions framed by us. News made available here are for informational purpose only. While utmost care has been taken in providing the same. We claim no responsibility for its accuracy. Readers of this blog who make their decision based on the information posted here are solely responsible for their actions.